Zion Market Research has published a new report titled “Primary Cells Market by Origin (Hematopoietic Cells, Renal Cells, Skin Cells, Lung Cells, Gastrointestinal Cells, Heart, Liver Cells, Skeletal and Muscle Cells, and Other Primary Cells), by Type (Human Primary Cells and Animal Primary Cells), and by End-User (Life Science Research Companies and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global primary cells market was valued at approximately USD 9 billion in 2017 and is expected to generate around USD 13 billion by 2024, at a CAGR of around 5.5% between 2018 and 2024.
The culture cells from an animal or plant are taken and grown under favorable and artificially controlled conditions. Majorly, there are three types of cell culture procedures—primary cell culture, secondary cell culture, and cell line. The excised tissue/cell is exposed to enzyme treatment and the separated cells are cultured under suitable conditions in the culture medium. The isolated primary cells are of two types: Adherent cells (Anchorage Dependent cells) and Suspension cells (Anchorage Independent cells).
Get PDF Sample Copy of this Report to understand the structure of the complete report @ https://www.zionmarketresearch.com/sample/primary-cells-market/news
Rapid growth in the biotechnology and biopharmaceutical industries, advantages of primary human cells over cell lines, increased demand for monoclonal antibodies, and partnerships, collaborations, and acquisitions are likely to drive the global primary cells market in the upcoming years. However, the high cost of advanced primary cells and concerns pertaining to contamination related to primary cell culture might limit the primary cells market in the future. Nevertheless, the progressive biomedical research using primary cells in 3D culture is likely to open new growth avenues in this global market in the future.
The primary cells market is classified market based on origin, type, and end-user. By origin, the primary cells market includes hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart, skeletal and muscle cells, and other primary cells. The hematopoietic cells are likely to register significant growth in the future, owing to the growing cancer research across the globe. By type, this market includes human primary cells and animal primary cells. Based on end-user, this global market includes life science research companies and research institutes.
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa comprise the regional segment of the global primary cells market. North America is projected to lead the primary cells market globally. The rising occurrences of cancer and the expansion of pharmaceutical and biotechnology industries in the region are the major factors driving the growth of the primary cells market in North America. The Asia Pacific primary cells market is expected to register the highest CAGR in the forecast timeframe, due to a large number of cancer patients and the introduction of awareness programs, conferences, and funding activities. Latin America is an important regional market and estimated to grow at a moderate rate, owing to developed healthcare infrastructure and rising awareness about the new technology among the regional population.
Few of the key players in primary cells market include Thermo Fisher Scientific, Merck KGaA, Lonza, Cell Biologics, PromoCell, ZenBio, STEMCELL Technologies, AllCells, American Type Culture Collection, and Axol Biosciences, among others.
This report segments the global primary cells market into:
Global Primary Cells Market: By Product
Global Primary Cells Market: By Type
Global Primary Cells Market: By End-User
Global Primary Cells Market: By Region
You can Buy This Report from Here @ https://www.zionmarketresearch.com/buynow/su/primary-cells-market/news